⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL431361 | 0.86 | — | — | |
| SCHEMBL8841950 | 0.67 | — | — | |
| SCHEMBL8112356 | 0.67 | — | — | |
| SCHEMBL62472 | 0.67 | — | — | |
| SCHEMBL30706490 | 0.65 | — | — | |
| Lithium SCHEMBL30706491 | 0.65 | — | — | |
| SCHEMBL118287 | 0.56 | — | — | |
| SCHEMBL2138977 | 0.52 | — | — | |
| SCHEMBL1518002 | 0.39 | — | — | |
| Water SCHEMBL19761 | 0.39 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2961 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024108147-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | DENALI THERAPEUTICS INC. (US) | 2024-05-23 | — | — | WO | claimed |
| US-20210238210-A1 | ANTIVIRAL COMPOUNDS | VIROVAX LLC | 2021-08-05 | — | — | US | claimed |
| EP-3484892-B1 | 1,2,4-TRIAZOLO-[3,4-B]-1,3,4-THIADIAZOLE DERIVATIVES | GALENICA S A (GR) | 2020-08-26 | — | — | EP | claimed |
| EP-2800738-B1 | HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR USE | NOVARTIS AG (CH) | 2020-04-08 | — | — | EP | claimed |
| EP-2047305-B1 | ORIENTED POLYMERIC SHEETS EXHIBITING DICHROISM AND ARTICLES CONTAINING THE SAME | TRANSITIONS OPTICAL INC (US) | 2019-11-20 | — | — | EP | claimed |
| US-10370388-B2 | Heterocyclic compounds and methods of their use | NOVARTIS AG (CH) | 2019-08-06 | — | — | US | claimed |
| US-20190194228-A1 | NEW 1,2,4-TRIAZOLO-[3,4-b]-1,3,4-THIADIAZOLE DERIVATIVES | ENERGONBIO TECHNOLOGIES S.A. (GR) | 2019-06-27 | — | — | US | claimed |
| EP-3484892-A1 | NEW 1,2,4-TRIAZOLO-[3,4-b]-1,3,4-THIADIAZOLE DERIVATIVES | Galenica S.A. (GR) | 2019-05-22 | — | — | EP | claimed |
| US-10205108-B2 | Compound | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2019-02-12 | — | — | US | claimed |
| US-RE47009-E1 | HDAC inhibitors and therapeutic methods using the same | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2018-08-28 | — | — | US | claimed |
| WO-2002092588-A2 | AROMATIC SULFONE HYDROXAMATES AND THEIR USE AS PROTEASE INHIBITORS | PHARMACIA CORPORATION (US) | 2002-11-21 | — | — | WO | claimed |
| US-6478988-B1 | Photochromic substituted naphthopyran compounds | BMC VISION-EASE LENS, INC. | 2002-11-12 | — | — | US | claimed |
| EP-1065206-B1 | Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents | PFIZER (US) | 2002-10-09 | — | — | EP | claimed |
| US-20020132223-A1 | Methods for modulating activity of the FXR nuclear receptor | CITY OF HOPE (US) | 2002-09-19 | — | — | US | claimed |
| US-20020080451-A1 | Novel naphthopyran compounds, photoresponsive compositions and lenses | VISION-EASE LENS, INC. | 2002-06-27 | — | — | US | claimed |
| WO-2002038563-A2 | CONDENSED PYRAZINDIONE DERIVATIVES AS PDE INHIBITORS | LILLY ICOS LLC (US) | 2002-05-16 | — | — | WO | claimed |
| EP-1065206-A1 | Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents | PFIZER INC. (US) | 2001-01-03 | — | — | EP | claimed |
| US-6127372-A | FOR TREATMENT OR PREVENTION OF VIRAL DISEASES, ESPECIALLY AIDS OR HIV | VERTEX PHARMACEUTICALS, INCORPORATED (US) | 2000-10-03 | — | — | US | claimed |
| EP-1016702-A2 | Photochromic substituted naphthopyran compounds | BMC Vision-Ease Lens Inc. (US) | 2000-07-05 | — | — | EP | claimed |
| US-5637590-A | Rapamycin amidino carbamates | AMERICAN HOME PRODUCTS CORPORATION (US) | 1997-06-10 | — | — | US | claimed |